APA (7th ed.) Citation

Choi, J., Medikonda, R., Saleh, L., Kim, T., Pant, A., Srivastava, S., . . . Lim, M. (2021). Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma. OncoImmunology, 10(1), 1. https://doi.org/10.1080/2162402X.2021.1956142

Chicago Style (17th ed.) Citation

Choi, John, et al. "Combination Checkpoint Therapy with Anti-PD-1 and Anti-BTLA Results in a Synergistic Therapeutic Effect Against Murine Glioblastoma." OncoImmunology 10, no. 1 (2021): 1. https://doi.org/10.1080/2162402X.2021.1956142.

MLA (9th ed.) Citation

Choi, John, et al. "Combination Checkpoint Therapy with Anti-PD-1 and Anti-BTLA Results in a Synergistic Therapeutic Effect Against Murine Glioblastoma." OncoImmunology, vol. 10, no. 1, 2021, p. 1, https://doi.org/10.1080/2162402X.2021.1956142.